Researchers have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease. Their surprising findings reveal that the peptide is more abundant, more neurotoxic, and exhibits a higher propensity to aggregate than amyloidogenic agents studied in earlier research, suggesting a potential role in new approaches